U.S. Food and Drug Administration Press Releases - EIN Presswire

Published on July 10, 2025 - 22:01 GMT

Hartford Bakery, Inc. Issues Allergy Alert on Undeclared Hazelnuts in “Lewis Bake Shop Artisan Style ½ Loaf”

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry

Published on July 10, 2025 - 18:51 GMT

Sheehan Brothers Vending Issues a Voluntary Recall Due to an Undeclared Sesame Allergen

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry

Published on July 10, 2025 - 16:01 GMT

A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: 100 Days of Embracing Gold-Standard Science, Transparency and Common ...

For Immediate Release: July 10, 2025 Statement From: As I mark my hundredth day on the job at the FDA, I’m proud to celebrate the agency’s accomplishments in the bipartisan effort to Make America Healthy Again. I came here with big questions: Why does it …

Distribution channels:

Published on July 10, 2025 - 13:28 GMT

FDA Embraces Radical Transparency by Publishing Complete Response Letters

For Immediate Release: July 10, 2025 The U.S. Food and Drug Administration (FDA) today published more than 200 decision letters, known as complete response letters (CRLs). The CRLs were issued in response to applications submitted to the FDA for approval …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 23:20 GMT

CHS Inc. Recalls Payback Champion Lamb Feed Due to Elevated Copper Health Risk

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry

Published on July 9, 2025 - 23:20 GMT

Natureen International Inc. Recalls Wei-Chuan Dried Black Fungus Slice (2.5oz) Because of Possible Health Risk

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry

Published on July 9, 2025 - 21:50 GMT

FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children

FDA News Release Stronger, More Transparent Notices Increase Public Safety For Immediate Release: July 09, 2025 The U.S. Food and Drug Administration today called for increased attention to product recall communications from industry leaders involved in …

Distribution channels: Food & Beverage Industry

Published on July 9, 2025 - 13:29 GMT

Compounding Quality Center of Excellence | Annual Conference - 08/25/2025

Conference | Mixed Meeting Patient Needs for Quality, Safety, Integrity and Access On This Page Date: August 25 - 28, 2025 Day1: Mon, Aug 25 2:00 p.m. - 05:00 p.m. ET Day2: Wed, Aug 27 9:00 a.m. - 06:00 p.m. ET Day3: Thu, Aug 28 9:00 a.m. - 04:30 p.m. ET …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 01:40 GMT

FDA Grand Rounds – Forensic Proteomics Applied to FDA-Regulated Products - 07/31/2025

On This Page Date: July 31, 2025 Time: 12:00 p.m. - 1:00 p.m. ET Speaker David M. Skelton, PhD Chemist National Forensic Chemistry Center Office of Specialty Laboratories and Enforcement Support Office of the Chief Scientist Office of the Commissioner U.S …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 01:27 GMT

Versace Real Honey for Men may be harmful due to hidden drug ingredients

[7-8-2025] The Food and Drug Administration is advising consumers not to purchase or use Versace Real Honey for Men, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores. FDA laboratory analysis …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 01:27 GMT

Black Panther Miracle Honey for Men may be harmful due to hidden drug ingredients

[7-8-2025] The Food and Drug Administration is advising consumers not to purchase or use Black Panther Miracle Honey for Men, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores. FDA laboratory analysis …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 01:27 GMT

Secret Miracle Honey Extra Strength may be harmful due to hidden drug ingredients

[7-8-2025] The Food and Drug Administration is advising consumers not to purchase or use Secret Miracle Honey Extra Strength, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores. FDA laboratory analysis …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 9, 2025 - 01:27 GMT

Black Horse Miracle Honey for Men may be harmful due to hidden drug ingredients

[7-8-2025] The Food and Drug Administration is advising consumers not to purchase or use Black Horse Miracle Honey for Men, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores. FDA laboratory analysis …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 8, 2025 - 22:21 GMT

Mondelēz Global LLC Conducts U.S. Voluntary Recall of Four Carton Sizes of RITZ Peanut Butter Cracker Sandwiches Due to Labeling ...

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry

Published on July 8, 2025 - 16:39 GMT

Dynamic Blending Specialists, Inc. - 701278 - 06/18/2025

Delivery Method: VIA Electronic Mail Reference #: 320-25-83 Product: Drugs Recipient: Recipient Name Mr. Gavin Victor Collier Dynamic Blending Specialists, Inc. 523 East 1750 N., Suite 100 Vineyard, UT 84059-8109 United States Issuing Office: Center for …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 8, 2025 - 16:38 GMT

Xtreme Tools International, Inc. - 706053 - 06/25/2025

Delivery Method: VIA Electronic Mail Reference #: 320-25-85 Product: Drugs Recipient: Recipient Name Mr. Ali Mithavayani Recipient Title Owner/Chief Executive Officer (CEO) Xtreme Tools International, Inc. 15400 NW 34th Avenue Opa Locka, FL 33054-2461 …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 8, 2025 - 16:38 GMT

Libby Laboratories, Inc. - 708259 - 06/27/2025

Delivery Method: VIA Electronic Mail Reference #: 320-25-87 Product: Drugs Recipient: Recipient Name Ms. Susan Carol Libby President Recipient Title President Libby Laboratories, Inc. 1700 Sixth Street Berkeley, CA 94710 United States Issuing Office: …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 7, 2025 - 20:31 GMT

Endothelin Receptor Antagonist REMS Information

Based on a new analysis of human pregnancy data compiled from the use of endothelin receptor antagonist (ERA) medicines for two decades, FDA has determined that risk evaluation and mitigation strategy (REMS) requirements related to embryofetal toxicity ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 7, 2025 - 20:31 GMT

Drug Trials Snapshot: ROMVIMZA

HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “ …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 7, 2025 - 20:31 GMT

FDA Public Meeting: BsUFA III Regulatory Science Program Interim Public Meeting - 09/18/2025

On This Page Date: September 18, 2025 Time: 9:00 a.m. - 3:00 p.m. ET Under the Biosimilar User Fee Act (BsUFA) reauthorization commitment letter for fiscal years 2023 to 2027 (BsUFA III), FDA committed to piloting a regulatory science program that focuses …

Distribution channels: Healthcare & Pharmaceuticals Industry